Filter
1768
Filtered Results: 1768
Text search:
CDC
et
al.
Featured
Recommendations
198
New Publications
406
Language
Document type
No document type
927
Guidelines
328
Studies & Reports
223
Manuals
102
Fact sheets
67
Strategic & Response Plan
55
Training Material
34
Infographics
15
Situation Updates
8
Resource Platforms
6
Brochures
2
Videos
1
Countries / Regions
Latin America and the Carribbean
49
Africa
47
Sierra Leone
44
Global
44
South Africa
35
Liberia
34
Ethiopia
33
Kenya
33
Western and Central Europe
33
India
32
Brazil
32
Russia
30
Zambia
27
West and Central Africa
27
Nigeria
25
Uganda
25
Colombia
23
Germany
22
Senegal
21
Congo, Democratic Republic of
19
Mozambique
19
East and Southern Africa
19
Guinea
18
Tanzania
18
Malawi
17
Bangladesh
16
Rwanda
14
Ukraine
14
Eastern Europe
14
Burkina Faso
13
Zimbabwe
13
Ecuador
13
Middle East and North Africa
13
Paraguay
13
Ghana
12
Namibia
11
USA
10
Bolivia
10
Angola
10
Spain
10
Haiti
9
Cameroon
8
Syria
8
Argentina
8
Myanmar / Burma
8
Asia
8
Venezuela
8
Guinea-Bissau
7
Nepal
7
Peru
7
Eastern Europe and Central Asia
7
Côte d’Ivoire / Ivory Coast
6
Botswana
6
Chile
6
Yemen
6
Philippines
5
Indonesia
5
Madagascar
5
Mali
4
Niger
4
South Sudan
4
Cambodia
4
Sudan
4
Eswatini/ Swaziland
4
South–East Asia Region
4
Vietnam
4
France
4
Lesotho
3
Congo-Brazzaville
3
Kazakhstan
3
Tunisia
3
Portugal
3
Morocco
2
Pakistan
2
Iraq
2
Lebanon
2
Turkey
2
Egypt
2
Chad
2
Thailand
2
Central African Republic
2
Dominican Republic
2
Honduras
2
Guatemala
2
Mexico
2
Western Pacific Region
2
Italy
2
Qatar
2
North America
2
Saudi Arabia
1
Somalia
1
Jordan
1
Afghanistan
1
China
1
Mauritania
1
Benin
1
Cuba
1
El Salvador
1
Libya
1
Nicaragua
1
Palestine
1
Albania
1
Southern Africa
1
Laos
1
Tajikistan
1
Kyrgyzstan
1
Gabon
1
Uruguay
1
Mauritius
1
United Kingdom
1
Morocco
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
619
Clinical Guidelines
178
Key Resources
79
Public Health
77
Women & Child Health
71
Capacity Building
66
Pharmacy & Technologies
33
Toolboxes
COVID-19
338
HIV
179
TB
154
Ebola
96
AMR
93
Rapid Response
92
Mental Health
60
Caregiver
38
Zika
37
Planetary Health
37
NTDs
31
NCDs
27
Cholera
18
Polio
17
Global Health Education
16
Pharmacy
16
Refugee
15
Disability
13
Specific Hazards
13
Conflict
11
Natural Hazards
11
Health Financing Toolbox
6
Social Ethics
1
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Guidance for General Medical and Specialised Mental Health Care Settings
Organizing and Delivering High Quality Care for Chronic Noncommunicable Diseases in the Americas
This is an abridged version of the 2019 Standards containing the evidence-based recommendations most pertinent to primary care. The tables and figures have been renum-bered from the original document to match this version. The complete 2019 Standards of Care do...
21 August 2020
This guidance provides specific considerations for the use of non-medical masks, also known as fabric masks, by children as a means for source control in the context of the current COVID-19 pandemic. It also advises on the use of medical masks for children under certain conditions.
The package provides practical, concise yet crucial information about the impact of COVID-19 on daily teaching practices as well as tips and suggestions to improve safety, well-being and learning, with students in face-to-face or remote settings.
The package speaks directly to the teachers. It ca...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Conflict, in its active or latent forms, is everywhere. The COVID-19 pandemic has demonstrated that public health emergencies can strike any country at any time. Given the universality of and interconnections between conflict, humanitarian crises, and public health emergencies, practitioners trained...
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
Calls for greater implementation research (IR) capacity came in the wake of compelling evidence that implementation strategies are critically important for the dissemination and facilitation of evidence-informed policies and interventions to tackle noncommunicable diseases (NCDs), thereby improving ...
Empfehlungen f ür das politische Handeln des Bundes und der Länder so wie angeschlossene Behörden
Version 01, veröffentlichtam 16.12.2020
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
